Lucia C. Lam

Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillance.

Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillance.

Journal: Prostate cancer and prostatic diseases

Published: June 14, 2018

Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer.

Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: November 30, 2017

Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease.

Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 31, 2017

Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens.

Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens.

Journal: European urology

Published: January 06, 2017

Comprehensive Determination of Prostate Tumor ETS Gene Status in Clinical Samples Using the CLIA Decipher Assay.

Comprehensive Determination of Prostate Tumor ETS Gene Status in Clinical Samples Using the CLIA Decipher Assay.

Journal: The Journal of molecular diagnostics : JMD

Published: January 05, 2017

Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patients.

Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patients.

Journal: Oncotarget

Published: November 16, 2016

Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case Report.

Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case Report.

Journal: Urology case reports

Published: August 04, 2016

Decipher correlation patterns post prostatectomy: initial experience from 2 342 prospective patients.

Decipher correlation patterns post prostatectomy: initial experience from 2 342 prospective patients.

Journal: Prostate cancer and prostatic diseases

Published: March 03, 2016

Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies.

Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies.

Journal: Oncotarget

Published: February 26, 2016

Decipher Genomic Classifier Measured on Prostate Biopsy Predicts Metastasis Risk.

Decipher Genomic Classifier Measured on Prostate Biopsy Predicts Metastasis Risk.

Journal: Urology

Published: December 12, 2015

Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy Specimens.

Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy Specimens.

Journal: The Journal of molecular diagnostics : JMD

Published: June 04, 2015

Showing 1-11 of 11

Last Updated: 09/26/2026